The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club

被引：42

作者：

Cavalier, E. ^{[1
]}

Bergmann, P. ^{[2
]}

Bruyere, O. ^{[3
]}

Delanaye, P. ^{[4
]}

Durnez, A. ^{[5
]}

Devogelaer, J. -P. ^{[5
]}

Ferrari, S. L. ^{[6
]}

Gielen, E. ^{[7
]}

Goemaere, S. ^{[8
]}

Kaufman, J. -M. ^{[8
,9
,10
]}

Toukap, A. Nzeusseu ^{[5
]}

Reginster, J. -Y. ^{[10
]}

Rousseau, A. -F. ^{[11
,12
]}

Rozenberg, S. ^{[13
]}

Scheen, A. J. ^{[14
]}

Body, J. -J. ^{[15
]}

机构：

[1] Univ Liege, CHU Liege, Dept Clin Chem, UnilabLg,CIRM, B-4000 Liege, Belgium

[2] Univ Libre Bruxelles, CHU Brugmann, Dept Radioisotopes, Brussels, Belgium

[3] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, B-4000 Liege, Belgium

[4] Univ Liege, CHU Liege, Dept Nephrol Dialysis Transplantat, B-4000 Liege, Belgium

[5] Catholic Univ Louvain, Clin Univ St Luc, Pole Pathol Rhumatismale, B-1200 Brussels, Belgium

[6] Hop Univ Geneve, Dept Bone Dis, Geneva, Switzerland

[7] Katholieke Univ Leuven, Dept Clin & Expt Med, Gerontol & Geriatr Sect, Leuven, Belgium

[8] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, Ghent, Belgium

[9] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium

[10] Ctr Acad Rech & Experimentat Sante SPRL CARES SPR, Liege, Belgium

[11] Univ Liege, CHU Liege, Burn Ctr, B-4000 Liege, Belgium

[12] Univ Liege, CHU Liege, Gen Intens Care Dept, B-4000 Liege, Belgium

[13] Univ Libre Bruxelles, Dept Gynaecol Obstet, Brussels, Belgium

[14] Univ Liege, CHU Liege, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium

[15] Univ Libre Bruxelles, CHU Brugmann, Dept Med, Brussels, Belgium

来源：

OSTEOPOROSIS INTERNATIONAL | 2016年 / 27卷 / 07期

关键词：

Biomarkers; Bone; Osteoporosis; RESISTANT ACID-PHOSPHATASE; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; PROSTATE-CANCER; ELDERLY-MEN; VERTEBRAL FRACTURE; DIABETES-MELLITUS; DOUBLE-BLIND; BURN INJURY; SCLEROSTIN;

D O I：

10.1007/s00198-016-3561-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The exact role of biochemical markers of bone turnover in the management of metabolic bone diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club aimed to provide a state of the art on the use of these biomarkers in different clinical or physiological situations like in postmenopausal women, osteoporosis in men, in elderly patients, in patients suffering from bone metastasis, in patients with chronic renal failure, in pregnant or lactating women, in intensive care patients, and in diabetics. We also gave our considerations on the analytical issues linked to the use of these biomarkers, on potential new emerging biomarkers, and on the use of bone turnover biomarkers in the follow-up of patients treated with new drugs for osteoporosis.

引用

页码：2181 / 2195

页数：15

共 100 条

[11] Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein [J].

Brunkow, ME ;

Gardner, JC ;

Van Ness, J ;

Paeper, BW ;

Kovacevich, BR ;

Proll, S ;

Skonier, JE ;

Zhao, L ;

Sabo, PJ ;

Fu, YH ;

Alisch, RS ;

Gillett, L ;

Colbert, T ;

Tacconi, P ;

Galas, D ;

Hamersma, H ;

Beighton, P ;

Mulligan, JT .

AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :577-589

[12] Monitoring of osteoporosis therapy [J].

Bruyere, Olivier ;

Reginster, Jean-Yves .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (06) :835-841

[13] Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values [J].

Cavalier, Etienne ;

Delanaye, Pierre ;

Vranken, Laura ;

Bekaert, Anne-Catherine ;

Carlisi, Agnes ;

Chapelle, Jean-Paul ;

Souberbielle, Jean-Claude .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) :1950-1956

[14] Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis [J].

Chu, PL ;

Chao, TY ;

Lin, YF ;

Janckila, AJ ;

Yam, LT .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (05) :1052-1059

[15] Bone health in cancer patients: ESMO Clinical Practice Guidelines [J].

Coleman, R. ;

Body, J. J. ;

Aapro, M. ;

Hadji, P. ;

Herrstedt, J. .

ANNALS OF ONCOLOGY, 2014, 25 :124-137

[16] Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid [J].

Coleman, RE ;

Major, P ;

Lipton, A ;

Brown, JE ;

Lee, KA ;

Smith, M ;

Saad, F ;

Zheng, M ;

Hei, YJ ;

Seaman, J ;

Cook, R .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4925-4935

[17] Consensus on the utility of bone markers in the malignant bone disease setting [J].

Coleman, Robert ;

Costa, Luis ;

Saad, Fred ;

Cook, Richard ;

Hadji, Peyman ;

Terpos, Evangelos ;

Garnero, Patrick ;

Brown, Janet ;

Body, Jean-Jacques ;

Smith, Matthew ;

Lee, Ker-Ai ;

Major, Pierre ;

Dimopoulos, Meletios ;

Lipton, Allan .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (03) :411-432

[18] Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status [J].

Costa, L ;

Demers, LM ;

Gouveia-Oliveira, A ;

Schaller, J ;

Costa, EB ;

de Moura, MC ;

Lipton, A .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :850-856

[19] Bone Turnover Markers Predict Bone Mass Development in Young Adult Men: A Five-Year Longitudinal Study [J].

Darelid, Anna ;

Nilsson, Martin ;

Kindblom, Jenny M. ;

Mellstrom, Dan ;

Ohlsson, Claes ;

Lorentzon, Mattias .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04) :1460-1468

[20] Type 2 diabetes mellitus and fracture risk [J].

Dede, Anastasia D. ;

Tournis, Symeon ;

Dontas, Ismene ;

Trovas, George .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (12) :1480-1490

← 1 2 3 4 5 6 7 8 9 10 →